Drug Profile
RX 77368
Alternative Names: ThymoliberinLatest Information Update: 18 Sep 1997
Price :
$50
*
At a glance
- Originator Reckitt Benckiser
- Developer Ferring Pharmaceuticals; Reckitt Benckiser
- Class Antidepressants; Cytoprotectives
- Mechanism of Action Thyrotropin releasing hormone stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Learning disorders; Major depressive disorder; Motor neuron disease; Peptic ulcer
Most Recent Events
- 18 Sep 1997 Discontinued-Clinical for Peptic ulcer in United Kingdom (unspecified route)
- 18 Sep 1997 Discontinued-II for Motor neuron disorders in Sweden (unspecified route)
- 18 Sep 1997 Discontinued-Preclinical for Learning disorders in United Kingdom (unspecified route)